| NO | TITLE | |
| P1 | Hatice Kurnaz | Preparation and Characterization of Salinomycin-Loaded Boron-Doped Mesoporous Bioactive Glass Nanoparticles as an Anti-Cancer Drug Delivery System |
| P2 | Zeliha Nur Yılmaz | In Silico Examination of Bifenilaminoketooxime Derivatives: Unraveling Anti-Inflammatory Potential and ADMET Characteristics |
| P3 | Selcan AKAR | Homology Modeling and In Silico Inhibitor Screening of Lactate Dehydrogenase from Theileria annulata |
| P4 | Mustafa Necati Haşimoğlu | In silico identification of novel Inhibitors targeting 1-deoxy-d-xylulose 5-phosphate reductoisomerase from neisseria gonorrhoeae |
| P5 | Neslisah Barlak | Preliminary evaluation of POFUT1 inhibitors as anti-cancer agents against head and neck cancer using in vitro models |
| P6 | Defne Çığ | Identification of Molecular Signatures and Therapeutic Targets for COVID-19 and PAH through Multiomics Data Integration |
| P7 | Nagehan ERSOY TUNALI | Identification of dysregulated mRNAs as therapeutic targets in Alzheimer\’s Disease and drug repurposing approaches. |
| P8 | Naimat Ullah | Leveraging High-Throughput Screening for Accelerated Drug Discovery: A Case Study in Targeted Cancer Therapies |
| P9 | A. Alper ÖZTÜRK | A drug delivery system that can be used in diseases caused by oxidative damage: Preparation and Characterization of Ferulic Acid Loaded PLGA-Based Nanosystems |
| P10 | A. Alper ÖZTÜRK | A system that can cross the blood-brain barrier in the treatment of Alzheimer: Donepezil hydrochloride incorporated Resomer RG 502 H nanoparticle systems |
| P11 | Edanur Düzgün | Development of New 1,4-Benzoquinone Derivatives as EGFR-TK Inhibitors |
| P12 | Betul Orucoglu | Discovery of Sars-CoV-2 3C-like protease (3CLpro) inhibitor by drug repurposing approach using biosafe Sars-CoV-2 Replicon |
| P13 | Can AYGÜN | Acinetobacter baumannii D-Alanine-D-Alanine Ligase (AbDDL) Enzyme as a Drug Target: Molecular Modelling, Docking, Classical Molecular Dynamics (MM MD) and Quantum Mechanical (QM/MM MD) Reaction Modelling |
| P14 | Lalehan Ozalp | In vitro and in silico investigation of inhibitory activities of 3-arylcoumarins and 3-phenylazo-4-hydroxycoumarin on MAO isoenzymes |
| P15 | Mustafa Erhan Özer | SVM-DO: Identification of Tumor-discriminating mRNA Signatures via Support Vector Machines Supported by Disease Ontology |
| P16 | Aysun İNAN GENÇ | Valdecoxib (VLX)-DSPC Model Membrane Interaction Explains the Ameliorative Effects of Selective COX-2 Inhibitors on Cancer Cell Lines in Terms of Biophysical Parameters |
| P17 | Zeynep Ozornek | Design of Nanoparticle Integrated Chitosan Microparticles for Controlled and Sustained Ocular Drug Delivery of Anti-Angiogenesis Peptide |
| P18 | Miray Cakiroglu | Computational evaluation of molecular imprinting monomers that selectively bind ApoE4 protein for Alzheimer\’s Disease diagnosis |
| P19 | YAĞMUR BİLİZ | Novel pyrazolidines: synthesis, characterization and antioxidant activity studies |
| P20 | Talha Islam | Computer-Aided Drug Design (CADD) of Multitarget-Directed Ligands (MTDLs) for Treatment of Various Neurological Disorders |
| P21 | Kamer Nisa BAZ | Computational Analysis of The Effect of Human Telomerase Mutations on Protein Complexation and Template RNA Binding |
| P22 | Nazif Ullah | Broad spectrum antiparasitic activity of Organotin (IV) derivatives and its Proteomic analysis |
| P23 | Nurgül Kaya | Computational evaluation of cell membrane destruction by Bacteriophage-K holin protein |
| P24 | Esra Albayrak Karahan | Sude Büyükkurt | Novel Anticancer Peptide Design; Computational Point of View |
| P25 | Şuara ŞAHİN | A Polypharmacological Approach Unveiling Subtype-Specific Drug Candidates for Alzheimer\’s Disease and Liver Cancer |
| P26 | Gizem Nur DURAN | Computational Construction LbpA – LbpB – lf Triple Complex |
| P27 | Handan Simsek | DRUG REPURPOSİNG AGAİNST LASSA VİRUS PROTEİNS BY USİNG IN SİLİCO METHODS |
| P28 | Nimet Karagülle | Development of biocompatible and biodegradable cryogels for potential drug delivery applications |
| P29 | Isil Ezgi Eryilmaz | Luteolin disrupts cell health as a pro-oxidant agent against PC3 metastatic castration-resistant prostate cancer cells |
| P30 | Sinem Nur Açıkgöz | Computational Analysis of Epileptic Encephalopathy Disease Mutations |
| P31 | Ekin CÜCÜ | Atakan AYDIN | Drug repurposing against PolTheta driven PARPi resistance in HR-deficient cancers |
| P32 | Iqra Akhtar | Extraction and rapid recovery of bioactive constituents from C. sativum seeds. |
| P33 | Merve Şansaçar | Targeting the C-SH2 domain of the Syk kinase by virtual drug screening to identify potential anticancer candidates |
| P34 | Öyküm Önel | Elif Bengü Kızılay | Determination of Novel and Non-Competitive MRP4 Inhibitors by Structure-Based Virtual Screening and Drug Discovery Methods |
| P35 | Rana Arıduru | Evaluation of Antioxidant Properties of Casir (Prangos Ferulacea (L.) Lindl.) and Phenolic Profile by HPLC |
| P36 | Esma Hande ALICI | ENZYMATIC AND NON-ENZYMATIC ANTIOXIDANT PROFILE OF BITTER DOCK PLANT GROWN IN SAKARYA REGION OF TURKEY |
| P37 | Esma Hande ALICI | SUBSTRATE SPECIFICITY DETERMINATION OF FRAGARIA ANANASSA L. PROTEASE |
| P38 | Alparslan Numan YILDIZ | DNA AND EGFR PROTEIN DOCKING OF HEXAHISTIDINE |
| P39 | Ekin CÜCÜ | Atakan AYDIN | Pol Theta Inhibitors in Cancer Therapy : Molecular Mechanisms and Therapeutic Potential |
| P40 | Harun Nalçakan | Computational Evaluation of potent SGLT1 Inhibitors: Sotagliflozin Derivatives Explored with Pharmacophore-Based Virtual Screening, Molecular Docking, and AI-Guided ADMET Assessment |
| P41 | Simay Denizkuşu | New Ibuprofen-based prodrug from tert-butyl alpha-hydroxymethacrylate |
| P42 | Segun Dogru | Investigation of Viomycin Pass Through MscS Ion Channel, an Antibacterial Drug Target |
| P43 | Hatice Başpınar Küçük | Design and Synthesis of Novel 1,3,4-Oxadiazoles as Potential Anticancer Agents |
| P44 | Perihan Kızılkaya | Synthesis, Characterization and Antimicrobial Activities of Tetra-Paraben Substituted Monospiro Cyclotriphosphazenes |
| P45 | Müge Didem ORHAN | INVESTIGATION OF CELLS AND CYTOKINES INVOLVED IN DEMYELINATION AND REMYELINATION PROCESS VIA THE MULTIPLE SCLEROSIS CUPRIZONE MODEL USING HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| P46 | Emre Can BULUZ | DESIGNING PEPTIDES TO PREVENT YAP-TEAD COMPLEX FORMATION BY INTEGRATION OF NON CANONICAL AMINO ACIDS INTO ROSETTA COMMONS |
| P47 | Aybüke Züleyha Kaya | Design, synthesis, and antimicrobial evaluation of novel thiazole derivatives: In vitro and in silico approaches |
| P48 | Sahra Setenay Baran | Identification of Dickkopf-1 Antagonist Candidates using Virtual Screening |
| P49 | Reyhan Metin Akkaya | Insights from Molecular Dynamics Simulations on TAU and MAP7 Unbinding Mechanisms |
| P50 | Derman Baştürk | Effect of Microtubule Curvature on Dynein Binding Explored through Molecular Dynamics Simulations |
| P51 | Sema Zeynep Yılmaz | Binding Strengths and Molecular Interactions of Self-Peptides with HLA-B*51:01 |
| P52 | Clara Xazal Buran | Elucidating the Conformational Dynamics and Activation Mechanism of CHK2 via Molecular Dynamics Simulations |
| P53 | Meryem Eren | Activation Mechanism of AKT: A Control Point of Cell Fate |
| P54 | Djelila Hammoudi-Triki | Proteomic-bioinformatic characterisation of an antimicrobial peptide isolated from the nontoxic fraction of scorpion venom |
| P55 | Şeyma ÖNNER | Antioxidant efficiency and xanthine oxidase (XO) inhibition activity of newly synthesized piperazine derivatives |
| P56 | THOMAS MAVROMOUSTAKOS | Chalcones derivatives as potential anti-inflammatory agents |
| P57 | THOMAS MAVROMOYSTAKOS | Probing the MAO enzymes with novel quaternary propargylamine derivatives |
| P58 | Defne Eşkin | Crafting Excellence in LIM Kinase 1 Inhibition: Pharmacophore-Based Virtual Screening and AI-Boosted ADMET Insight in Molecular Docking Investigation |
| P59 | Beril Uras | Guiding TRK Inhibition Strategies: Revelations from Pharmacophore-Based Virtual Screening, Molecular Docking Analysis, and AI-Facilitated In Silico ADMET Profiling |
| P60 | Yiğit Akkan | Assessment of KRAS Inhibitors through Pharmacophore-Based Virtual Screening, Molecular Docking and AI-Enhanced ADMET Profiling via the Pharmit Server |
| P61 | Thomas Mavromoustakos | Pharmacodynamic and pharmacokinetic studies of potential bioactive natural products in two Achillea species found in Greece |
| P62 | Nikolai Li-Zhulanov | Design, synthesis and antifungal activity of new monoterpene-containing azoles |
| P63 | Nur Eksi | Conformational Effects of Post-Translational Modifications in MtrA |
| P64 | Nadjiba Zegheb | Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis |
| P65 | Muhammet Baldan | Using combination of different sets of features of molecules for improved prediction of solubility |
| P66 | BEYZANUR TUTUŞ | Synthesis of new N-(1,3-dioxolo[4,5-f]benzothiazol-2-yl)-2-(substituted)acetamide/propanamide and evaluation of their AChE and BChE activities |
| P67 | Tarık Emre Öztürk | New Biologically Active Hybrid Indole Compounds |
| P68 | Ezgi BİRDAL | Synthesis of Novel Quinone Derivatives as Promising Antioxidant Agents |
| P69 | Cansu YILMAZ | Investigation of the Effects of 3-Carene on Neuronal Excitability: An ex vivo electrophysiological study |
| P70 | Makbule Beyza Şen | Silk Fibroin as a Promising Vehicle for Sulfonamide Drug Formulations |
| P71 | Tugba TAS | Discovery of Novel Hsp90 Inhibitors Bearing 2H-Triazole Ring |
| P72 | Hasan Tahsin ŞEN | Investigation of Synthesis and The Biological Effect Profiles of New Benzimidazole Derivative |
| P73 | Berkay DEMİRÇİ | REPOSITIONING OF TRIMETAZIDINE: EFFECTS IN AN IN VITRO MODEL OF PSORIASIS |
| P74 | Elif GÜN | ANTIPROLIFERATIVE EFFECT OF ASTRAGALOSIDE-IV IN A CELL CULTURE MODEL OF PSORIASIS |
| P75 | Merve YILMAZ | Exploring of Interaction Between Bcl-2 Protein and Novel BH3 Mimetics with X-ray Crystallography |
| P76 | Sevgi Döndü Özen | NIK Signaling and Exercise-Dependent Drug Targets |
